No menu items!

Brazil’s health regulator approves first one-pill HIV treatment

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (ANVISA) has approved the first HIV treatment combining two different substances in a single pill. The new drug is a combination of lamivudine and sodium dolutegravir.

Previously, patients were required to take two pills or more, depending on the type of treatment.

"The approval represents a breakthrough in the treatment of people with the virus that causes AIDS, since it combines two antiretroviral drugs that were not available in a single pill in a daily dose," the regulator said in a statement.

According to the package insert approved by ANVISA, the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content